NEWTOWN, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by CUSO Financial Services, LP (“CUSO”). CUSO learned of suspicious activity on or about January 19, 2024. To join this case, go HERE.
About CUSO Financial Services, LP
CUSO Financial Services provides various investment advisory services such as brokerage, online trading, retirement planning, portfolio management, insurance, and wealth management.
What happened?
On or around January 19, 2024, CUSO identified unusual activity involving a third-party vendor responsible for FINRA-related communications. An investigation revealed that some personal information, including names and personal identifiers, may have been exposed. More than 75,000 individuals have been affected by this data breach.
How can I protect my personal data?
If you receive a data breach notification, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Additionally, you should consider legal options for mitigating such risks.
Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for customers who may have had their sensitive personal and patient data compromised by the CUSO data breach.
For more information, please contact:
Marc H. Edelson, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492
Email: medelson@edelson-law.com
Web: www.edelson-law.com
About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so counsel does not represent you unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing now. Your ability to share in any potential future recovery does not depend on serving as lead plaintiff.
